The largest database of trusted experimental protocols

53 protocols using cell lysis buffer

1

NHLRC2 Cleavage by Caspases

Check if the same lab product or an alternative is used in the 5 most similar protocols
293FT cells (Invitrogen) were transfected with expression vectors for wild-type or mutant NHLRC2-HA using polyethyleneimine “MAX” transfection reagent (Polysciences, Warrington, PA, USA) and then lysed in Cell Lysis Buffer (BioVision, Milpitas, CA, USA). Aliquots of lysates were incubated with 1 unit of recombinant active caspases (BioVision) in 1 × Reaction Buffer (BioVision) at 37 °C for 1 h. Reactions were terminated by adding Laemmli sample buffer and boiling at 95 °C for 5 min. Cleavage was evaluated by immunoblotting using an anti-NHLRC2 antibody.
+ Open protocol
+ Expand
2

FasL-Induced T Cell Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human T cells were stimulated for 3 days with anti-CD3 and anti-CD28, and the cells were then washed and cultured in complete RPMI with IL2 (10 µg/mL) for 4 additional days. For western blot analysis, 10 mL of stimulated primary human T cells (1.5 million cells/mL) in RPMI with IL2 were then treated with the indicated compounds for 1h prior to addition of FasL (1 µL of 100 µg/µL stock solution of MegaFasLigand™ in water, final concentration =10 ng/mL, Adipogen). After 3 hours, cells were harvested by centrifugation, washed in PBS and lysed in cell lysis buffer (BioVision, 1067-100) with 1 × cOmplete protease inhibitor (Roche) and 40 µg of each sample were separated by SDS-Page on 14% polyacrylamide gels. The gels were transferred to nitrocellulose membranes and were immunoblotted overnight with the indicated antibodies. For measurements of cell viability, in triplicate for each condition, 150,000 cells (100 µL of 1.5 million cells/mL ) were plated in 96-Well Optical-Bottom Plates. FasL was used at the same concentration indicated above with a 30 minute pre-incubation with compounds at the indicated concentrations, followed by 4 hours with FasL or DMSO. 20 × compound stock solutions were made in RPMI immediately before use. Cell viability was measured with CellTiter-Glo® Luminescent Cell Viability Assay (Promega) and was read on a Biotech Synergy 4 plate reader.
+ Open protocol
+ Expand
3

Antibody Array Analysis of CR and NR EVs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For antibody array, CTB- and AV-EVs isolated from CR and NR plasma pools were lysed with cell lysis buffer (#K269; Biovision) and 100 μL of the protein lysate were analyzed using the Fullmoon Biosystems Explorador Antibody (#ASB600, Fullmoon Biosystems) according to manufacturer’s instructions. We also conducted the same analysis with 100 μL of crude plasma (without EVs isolation) from both patient pools. After the immune reaction, following the manufacturer’s recommendations, the arrays were scanned and the values were normalized using GenePix Pro 7 software (Molecular Devices) to correct for any technical, chip-to-chip, or day-to-day variations. Since in the matrix there were two replicates of each spot, the relative expression means between the replicates were calculated. The reactivity against the controls contained in each matrix was used as background cutoff, and the reactivity higher than the background was classified as present and the lower reactivity as absent.
+ Open protocol
+ Expand
4

FasL-Induced T Cell Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human T cells were stimulated for 3 days with anti-CD3 and anti-CD28, and the cells were then washed and cultured in complete RPMI with IL2 (10 µg/mL) for 4 additional days. For western blot analysis, 10 mL of stimulated primary human T cells (1.5 million cells/mL) in RPMI with IL2 were then treated with the indicated compounds for 1h prior to addition of FasL (1 µL of 100 µg/µL stock solution of MegaFasLigand™ in water, final concentration =10 ng/mL, Adipogen). After 3 hours, cells were harvested by centrifugation, washed in PBS and lysed in cell lysis buffer (BioVision, 1067-100) with 1 × cOmplete protease inhibitor (Roche) and 40 µg of each sample were separated by SDS-Page on 14% polyacrylamide gels. The gels were transferred to nitrocellulose membranes and were immunoblotted overnight with the indicated antibodies. For measurements of cell viability, in triplicate for each condition, 150,000 cells (100 µL of 1.5 million cells/mL ) were plated in 96-Well Optical-Bottom Plates. FasL was used at the same concentration indicated above with a 30 minute pre-incubation with compounds at the indicated concentrations, followed by 4 hours with FasL or DMSO. 20 × compound stock solutions were made in RPMI immediately before use. Cell viability was measured with CellTiter-Glo® Luminescent Cell Viability Assay (Promega) and was read on a Biotech Synergy 4 plate reader.
+ Open protocol
+ Expand
5

Syndecan-1 Levels in Sepsis Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were injected IP with 50 µL saline, 125 µg S. aureus LTA or 500 ng TNFα, n = 5. Four hours after, the mice were anaesthetized with a subcutaneous injection of a mixture of ketamine and xylazine. Peritoneal lavage was done with 2 mL of clinical grade saline. Blood was collected via cardiac puncture in a heparinized syringe. Peritoneal effluent and blood were centrifuged at 1188×g. Samples of the abdominal wall were collected and immediately frozen in liquid nitrogen. The tissues were homogenized in cell lysis buffer (BioVision, Milpitas, CA, USA). Blood plasma and the supernatant from the tissue homogenate were analyzed at a 50-fold dilution. Peritoneal effluent was analyzed at a 10-fold dilution in PBS. Syndecan-1 levels in the tissue homogenate, peritoneal effluent and blood plasma were measured with a commercially available ELISA kit for mouse syndecan-1 (E91966Mu; USCNK Life Sciences Inc., Wuhan, China). To account for differences in tissue sample sizes, a Bradford assay was performed to measure total protein concentration in tissue homogenates and results were normalized to the total protein recovered.
+ Open protocol
+ Expand
6

Proteasome Activity Fluorescence Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After being treated with I-Trp for designated time periods, cells were collected and resuspended in cell lysis buffer (BioVision). Aliquots of cell lysates (100 μg) were incubated with 1 μM of fluorescent proteasome substrate (BioVision) for 30 min at 37 °C. The fluorescent intensity was read using a fluorimeter with an exciting wavelength at 355 nm and emission wavelength at 405 mm and presented as relative proteasome activity.
+ Open protocol
+ Expand
7

Cell Lysis and Immunoblot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with cell lysis buffer (Biovision, Milpitas, CA) including a protease inhibitor cocktail (Roche) for 20 min on ice. Lysed cells were centrifuged for 20 min at 12,000 rcf and supernatant was collected and frozen at −80°C until final analysis. An appropriate amount of protein was applied per lane for immunoblot analysis. Free binding sites of the nitrocellulose membrane containing the cellular proteins were blocked with blocking buffer (5% milk powder in TBS-T). Primary murine antibodies were used at a 1:1,000 (anti-human IL-16, clone 70719; R&D Systems), 1:3,000 (anti-human β-catenin, clone H102; Santa Cruz), and 1:5,000 dilution (anti-human GAPDH, clone 6C5; Santa Cruz), respectively. The secondary HRP-labeled antibody (R&D Systems) was used at a 1:5,000 dilution and signals were detected using chemiluminescent ECL solution.
+ Open protocol
+ Expand
8

Caspase-3 Activity Assay in NCKU-21 Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seeded cells (106 cells/dish) were treated with 2 μM NCKU-21 for 0, 12, and 24 hr. After that, cells were trypsinized and lysed with chilled cell lysis buffer (#1067–100; BioVision, Milpitas, CA, USA). Cell lysates containing 100 μg of protein were diluted to a total volume of 50 μL and then mixed with 50 μL of 2× reaction buffer (#1068–20; BioVision). After that, 5 μL of DEVD-pNA (4 mM in DMSO; #1008; BioVision), a caspase-3 substrate, was added for incubation at 37°C for 2 hr. Caspase activity was determined by measuring the absorbance of the released pNA at 405 nm and is shown as the multiple of change compared to that of the control group (without NCKU-21 treatment).
+ Open protocol
+ Expand
9

Caspase-3 Activation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 100 mm plates, incubated for 24 h to permit adherence, and then treated with 0, 125 and 250 nM DS-3032b for 48 h. After cell lysis in Cell Lysis Buffer (BioVision), 50 μg protein were incubated with Ac-DEVD-AFC (Biomol) at 37°C for 1 h, and caspase 3 activity was measured with a multi-well fluorescence plate reader.
+ Open protocol
+ Expand
10

Protein Expression Analysis of Autophagy and Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins were obtained using cell lysis buffer (BioVision, USA). ExKine Nuclear and Cytoplasmic Protein Extraction Kit (KTP3001, Abbkine, USA) was used to separate and extract proteins from the nucleus and cytoplasm, respectively. The protein samples were separated by 10% SDS-PAGE gels and subsequently transferred to nitrocellulose membranes. The primary antibodies including CKIP-1 (ab91489, abcam, USA), LC3 (ab51520, abcam, USA), Beclin-1 (ab207612, abcam, USA), p62 (ab109012, abcam, USA), KEAP1 (ab196346, abcam, USA), NRF2 (ab76026, abcam, USA), cleaved-caspase3 (ab2303, abcam, USA), caspase3 (ab13847, abcam, USA), cleaved-caspase7 (ab256469, abcam, USA), and caspase7 (ab32522, abcam, USA) are incubated with membrane at 4°C overnight. HRP-conjugated goat anti-rabbit IgG secondary antibody (ab6721, abcam, USA) was incubated at room temperature for 2 h. GAPDH (ab181602, abcam, USA) was presented as an internal control of total protein. Lamin B2 (ab8983, abcam, USA) was used as the internal control of nuclear protein. Enhanced chemiluminescence reagent (Thermo Fisher Scientific, Inc., USA) was used to visualize the protein bands in a BioRad ChemiDoc XRS Imaging system (Hercules, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!